HCV and Autoimmunity in Rheumatic Diseases.

Curr Rheumatol Rev

Rheumatology Clinic "Mario Carrozzo", Department of Medical and Surgical Sciences, University of Foggia, "Policlinico Riuniti" Universitary Hospital, Viale Pinto, 1-71121Foggia, Italy.

Published: June 2022

HCV is a global health problem affecting mainly the liver and is often characterized by extrahepatic manifestations mediated by autoimmune reactions. Among these, arthritis and arthralgia are most frequent, as well as the presence of cryoglobulinemia that may induce vasculitis and sicca syndrome. Thus, HCV appears to be a trigger for an autoimmune response, as demonstrated by the finding of autoantibody in a high percentage of serum of these patients. Therefore, it is important that clinicians recognize these autoimmune manifestations as symptoms due to an autoimmune activity triggered by HCV in order to give the correct diagnosis and start an effective therapeutic strategy. Therefore, clinical examination, searching of markers of infection, as well as autoantibody patterns should be performed to make a correct differential diagnosis. The treatment should be based on antiviral drugs associated with immunosuppressive drugs according to autoimmune manifestations.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1573397117666210812141524DOI Listing

Publication Analysis

Top Keywords

autoimmune manifestations
8
autoimmune
5
hcv
4
hcv autoimmunity
4
autoimmunity rheumatic
4
rheumatic diseases
4
diseases hcv
4
hcv global
4
global health
4
health problem
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!